In accordance with the provisions of the Regulations on the Administration of Veterinary Drugs and the Measures for the Administration of Approval Numbers for Veterinary Drug Products, and upeview by the Ministry of Agriculture and Rural Affairs, Luoyang Worpson Biological Engineering Co., Ltd. is hereby approved to produce the Inactivated Vaccine against BoNodular Dermatitis (NMG Strain, Suspension Culture), and the approval number for the veterinary drug product is hereby issued.

1.Chairman Wang Shanpu of Modern Biological Group made an annual summary and planned a new blueprint for development. In 2025, the deepened its focus on the life and health industry, worked hard to overcome difficulties, innovated and developed, solidified the foundation of research and development, and achieved a dual increase brand influence and team collaboration efficiency, successfully completing various business tasks. In 2026, the Group will take technological innovation as the core, unite as one, strive for, and work together to create a new situation of high-quality development.